Alison H. Mosca
Independent DirectorMs. Alison H. Mosca serves as Director at Clene Nanomedicine, Inc. She serves as Independent Director at Clene Inc. since September 2019. She serves as the Managing Director and Chief Executive Officer at Kensington Capital Holdings, LLC, the firm she co-founded in 2008. She has been Director of Clene Nanomedicine Inc. since September 2019. Ms. Mosca has experience, in private family wealth management, including wealth structuring, preservation and transfer, philanthropic advising, tax, investment and risk management counsel. In the five and half years prior to founding Kensington Capital Holdings, she built a multi-family office within Audax Group. Prior to her work at Audax Group, Ms. Mosca spent over seven years at PricewaterhouseCoopers. Her experience at PricewaterhouseCoopers included the Private Client Group & Audit Assurance serving a variety of clients, including broker dealers, venture capital & private equity funds and their general partners, investment managers, insurance, high tech & and manufacturing companies. Ms. Mosca is a Certified Public Accountant, she received her MS with distinction in Personal Financial Planning from Bentley University and her BS, cum laude with university honors program distinction, in Accounting from Northeastern University.
Positions
- Company NameClene Inc.Stock CodeCLNNPositionIndependent DirectorColleagues
- RERobert EtheringtonCEO, President & Director
- DJDavid J. MatlinIndependent Chairman of the Board
- MRMorgan R. BrownChief Financial Officer
- MGMark G. MortensonChief Science Officer
- JMJerry MiragliaGeneral Counsel & Corporate Secretary
- MAMary Anne McneilHead of Human Resources
- SJShalom JacobovitzIndependent Director
- RNReed Neil WilcoxIndependent Director
